Cite

HARVARD Citation

    Scheffler, M. et al. (2020). Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations. Lung cancer. pp. 40-48. [Online]. 
  
Back to record